Paperback
Unraveling apathy: disorders, diagnosis, neurobiology, and emerging treatments explained.

Apathy, 1st Edition

Clinical and Neuroscientific Perspectives from Neurology and Psychiatry

$228.46

  • Paperback

    300 pages

  • Release Date

    19 August 2021

Check Delivery Options

Summary

Apathy is characterized by loss of motivation, decreased initiative, and emotional blunting. It is highly prevalent in neurological, and psychiatric disorders like Alzheimer’s disease, traumatic brain injury, schizophrenia, Parkinson’s disease, Huntington’s disease, cerebrovascular disorders, and mild behavioural impairment. It has negative outcomes including impairments in activities of daily living, caregiver burden, and higher rates of institutionalization and mortality.

The defini…

Book Details

ISBN-13:9780198841807
ISBN-10:0198841809
Author:Krista Lanctot, André Aleman
Publisher:Oxford University Press
Imprint:Oxford University Press
Format:Paperback
Number of Pages:300
Edition:1st
Release Date:19 August 2021
Weight:506g
Dimensions:15mm x 155mm x 234mm
A-Format
B-Format
C-Format
Apathy, 1st Edition by Krista Lanctot - ISBN: 9780198841807
155 × 234 mm
A4
mm / in
About The Author

Krista Lanctot

André Aleman received his master’s degree in Psychology (Neuropsychology and Psychophysiology) at Utrecht University in 1997, where he also obtained his PhD (cum laude) in 2001. His current research interests concern the neural underpinnings of cognitive and affective dysfunctions in psychosis and depression, in addition to changes in cognitive brain function during aging. In 2006, he received a European Young Investigator (EURYI) Award (1.2 M euro) from the European Science Foundation. In 2011 and 2012, he received large grants (1.5 M euro each) from the Netherlands Organization for Scientific Research (VICI) and the European Research Council (ERC Starting/consolidator grant).

Dr. Krista Lanctôt is a Senior Scientist in the Hurvitz Brain Sciences Program at Sunnybrook Research Institute, the head of the Neuropsychopharmacology Research Group, and the Executive Director of the Medical Outcomes and Research in Economics (MORE) Research Centre. She is a full professor in the Departments of Psychiatry and Pharmacology & Toxicology at the University of Toronto. She is the Vice Chair of Basic and Clinical Research in the Department of Psychiatry at the University of Toronto. Dr. Lanctôt is an active researcher in clinical pharmacology and has published over 300 manuscripts. Her research focuses on optimizing the pharmacotherapy of cognition and neuropsychiatric symptoms associated with dementia and predementia states.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.